Diseases and Conditions Information
Diseases and Conditions Information.
Quick Links:  Asthma & Allergies |  Cancer  |  Depression  |  Anxiety  |  Diabetes  
BROWSE DISEASES AND CONDITIONS DIRECTORY
Medical Resource for all diseases and conditions information - cancer, neurological disorders, birth defects, AIDS, alzheimer's.

ADD and ADHD
Adrenal
AIDS
Allergies
Anxiety
Birth Defects
Blood Disorders
Cancer
Cardiovascular Disorders
Communication Disorders
Depressive Disorders
Diabetes
Digestive Disorders
Dyslexia
Ear, Nose & Throat Disease
Endocrine Disorders
Endometriosis
Eye Disorders
Genetic Disorders
Genitourinary Disorders
Halitosis
Hangover
Hemorrhoids
Hormonal Disorders
Immune Disorders
Infectious Diseases
Insulin Resistance
Miscellaneous
Musculoskeletal Disorders
Neurological Disorders
Nutrition Disorders
Organizations
Parathyroid
Pituitary
Polycystic Ovarian Syndrome
Pregnancy Complications
Premature Ejaculation
Rare Disorders
Registries
Conditions & Diseases Resources
Respiratory Disorders
Sexual Transmitted Diseases
Skin Disorders
Sleep Disorders
Thyroid
Wounds & Injuries

Hansen's Diseases
Outlines the symptoms, testa/diagnosis, causes and risk factors and treatment of this diseases
Agoraphobia
All about Agoraphobia - Anxiety, Dyspnea, Stress, all are symptoms of treatable depression
Down Syndrome
Learn about this genetic disorder, the causes and medical treatment
DISEASES AND CONDITIONS NEWS  
Stretching may ease women's depression and menopause symptoms
By Reyna Gobel (Reuters Health) – Stretching just 10 minutes a day might help ease menopause and depression symptoms in middle-aged women, a small study suggests. “Light-intensity exercises such as stretching have not been previously evaluated for its impact on menopausal and depressive symptoms,” lead researcher Yuko Kai told Reuters Health by email. Forty Japanese women, ages 40 to 61 years, participated in the study at the Physical Fitness Research Institute, Meiji Yasuda Life Foundation of Health and Welfare in Tokyo.

Finding A Cure Wouldn’t Mean We’ve Defeated Cancer
<p><a href="http://www.huffingtonpost.com/entry/biden-moonshot-cancer-cure_us_5664d285e4b08e945fefe20a?ncid=txtlnkusaolp00000592"><img src="http://l2.yimg.com/bt/api/res/1.2/reTEFn6.Plg7ad9lZHAG8w--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cT03NTt3PTEzMA--/http://media.zenfs.com/en-US/homerun/huffingtonpost.com.rss/08ffd71ff99a86e1979cb24d1b57b245" width="130" height="86" alt="Finding A Cure Wouldn’t Mean We’ve Defeated Cancer" align="left" title="Finding A Cure Wouldn’t Mean We’ve Defeated Cancer" border="0" /></a>WebMD wasn&#039;t a research option when Ivy Brown was diagnosed with Hodgkin&#039;s lymphoma in 1974, so her mother looked up her 12-year-old daughter&#039;s condition the old-fashioned way, in a hardcover medical volume.&quot;It just said &#039;fatal,&#039;&quot; Brown explained. Having moved the family to London a month earlier, Brown&#039;s parents were still trying to liaise...</p><br clear="all"/>

Limited protection of GSK's malaria vaccine dwindles in 7 years
<p><a href="http://news.yahoo.com/limited-protection-gsks-malaria-vaccine-dwindles-7-years-210505986--finance.html"><img src="http://l1.yimg.com/bt/api/res/1.2/yjAJNd7OSU_AqnOEiw2ueA--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cT03NTt3PTEzMA--/http://media.zenfs.com/en_us/News/Reuters/2016-06-29T210505Z_1_LYNXNPEC5S1NM_RTROPTP_2_USA-PHARMA-CONFLICTS.JPG" width="130" height="86" alt="Signage for GlaxoSmithKline is seen on its offices in London, Britain" align="left" title="Signage for GlaxoSmithKline is seen on its offices in London, Britain" border="0" /></a>The world&#039;s first malaria vaccine, developed by GlaxoSmithKline, provides some protection after three doses but its effect dwindles to almost nothing after seven years, scientists said on Wednesday. Publishing a long-term study of the vaccine - called RTS,S or Mosquirix and designed for children in Africa where the disease claims most of its victims - researchers said the decline in its efficacy over time is fastest in children living in areas with higher than average rates of malaria. This raises questions about whether Mosquirix can play a meaningful role in fighting malaria, they said, and suggests a four-dose schedule would be needed if it were used.</p><br clear="all"/>

Simple questions predict decline after breast cancer treatment
By Kathryn Doyle (Reuters Health) – Within one year of starting treatment, many older women with early stage breast cancer lose the ability to complete some tasks of daily living, and a 13-item survey can help predict who they will be, researchers say. The study of U.S. breast cancer patients found one in five women lost functional abilities necessary to living independently in the community and at home, said lead author Dr. Cynthia Owusu of Case Western Reserve University in Cleveland, Ohio. Scores on the survey, which was originally developed to predict decline in elderly people without cancer, strongly predicted who would be most affected a year later.

Following prevention guidelines linked to lowered risk for cancer
By Kathryn Doyle (Reuters Health) – Keeping active and eating healthy really does seem to reduce the odds of getting certain cancers and dying from them, according to a new review of past research. The analysis of 12 large studies found significant reductions in breast, endometrial and colorectal cancers in particular among people who consistently followed cancer-prevention lifestyle guidelines compared to those who didn’t. “What is most interesting to me is how much cancer can be reduced by our lifestyle behaviors,” said lead author Lindsay N. Kohler of the University of Arizona Mel and Enid Zuckerman College of Public Health in Tucson.

Biden outlines 'Moonshot' initiatives to fight cancer
<p><a href="http://news.yahoo.com/biden-outlines-moonshot-initiatives-fight-cancer-164117399.html"><img src="http://l2.yimg.com/bt/api/res/1.2/uD042_4nu4V64zs2HCiCLw--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cT03NTt3PTEzMA--/http://media.zenfs.com/en_us/News/Reuters/2016-06-29T164440Z_1_LYNXNPEC5S1B2_RTROPTP_2_USA-SECURITY-BIDEN.JPG" width="130" height="86" alt="U.S. Vice President Joe Biden delivers remarks at a conference of the Center for New American Security think tank in Washington" align="left" title="U.S. Vice President Joe Biden delivers remarks at a conference of the Center for New American Security think tank in Washington" border="0" /></a>By Toni Clarke WASHINGTON (Reuters) - U.S. Vice President Joseph Biden on Wednesday announced plans as part of the administration&#039;s &quot;Cancer Moonshot&quot; initiative, aimed at speeding development of treatments by cutting bureaucracy and easing collaboration between scientists, industry, patients and government. Speaking at a cancer summit at Howard University in Washington, Biden made an impassioned plea for increased urgency in the fight against cancer. Biden&#039;s son Beau died last year at age 46 from brain cancer, something Biden said helps inform his passion for the project.</p><br clear="all"/>

Biden threatens funding cut if cancer trials conceal results
<p><a href="http://news.yahoo.com/biden-hosting-cancer-summit-try-accelerate-research-100209657--politics.html"><img src="http://l2.yimg.com/bt/api/res/1.2/IKUAnb.aXMPC8G9olVVcmQ--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cT03NTt3PTEzMA--/http://media.zenfs.com/en_us/News/ap_webfeeds/12580e35fa7a4dc68566ff2cc83f72f6.jpg" width="130" height="86" alt="Vice President Joe Biden pauses as he speaks at the Cancer Moonshot Summit at Howard University in Washington, Wednesday, June 29, 2016. Biden is trying to bolster efforts to cure cancer at this summit focusing on research and innovative trials. (AP Photo/Carolyn Kaster)" align="left" title="Vice President Joe Biden pauses as he speaks at the Cancer Moonshot Summit at Howard University in Washington, Wednesday, June 29, 2016. Biden is trying to bolster efforts to cure cancer at this summit focusing on research and innovative trials. (AP Photo/Carolyn Kaster)" border="0" /></a>WASHINGTON (AP) — Vice President Joe Biden threatened Wednesday to pull federal funding for cancer studies that fail to publicly disclose their results, putting pressure on researchers, clinicians and drug companies to speed up progress toward cancer cures.</p><br clear="all"/>

Tesaro's ovarian cancer drug study succeeds, shares soar
(Reuters) - Tesaro Inc said its experimental ovarian cancer drug niraparib met the main goal of prolonging survival in patients, without the disease worsening, in a late-stage trial, sending its shares to a record high. About 22,000 women are diagnosed with ovarian cancer in the United States every year, and nearly 80 percent are diagnosed after it has progressed to a severe stage. The trial which enrolled more than 500 patients, included subjects some of whom had a BRCA gene mutation.


Health Directory | About Us | Submit Your Site | How to link to us | Contact Us
DiseasesConditions lists all the major web sites and companies for practically every country in the world. Browse our massive index of thousands of dedicated diseases and conditions web sites. All logos, trademarks and other propriety marks belong to their respective owners and do not reflect an association or recommendation by any of the parties.
©2005 DiseasesConditions.com - All Rights Reserved.